Treatment of radiation-induced myelopathy with bevacizumab

Saved in:
Bibliographic Details
Published in:Clinical & translational oncology 2020-06, Vol.22 (6), p.957-960
Main Authors: Cañedo, G., Solis, I., González-San Segundo, C., Madero, L., Lassaletta, A.
Format: Article
Language:English
Subjects:
Adrenal Cortex Hormones - administration & dosage
Angiogenesis Inhibitors - administration & dosage
Antineoplastic Agents, Immunological - administration & dosage
Astrocytoma - radiotherapy
Bevacizumab - administration & dosage
Child
Correspondence
Female
Humans
Medicine
Medicine & Public Health
Necrosis
Oncology
Radiation Injuries - drug therapy
Radiation Injuries - pathology
Radiotherapy, Intensity-Modulated - adverse effects
Spinal Cord - drug effects
Spinal Cord - pathology
Spinal Neoplasms - radiotherapy
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1699-048X
1699-3055
DOI:10.1007/s12094-019-02209-5